Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Queen's University, Belfast | OTHER |
Not provided
Not provided
Not provided
Not provided
Coronavirus disease 2019 (COVID-19) which is caused by the virus SARS-CoV-2 has resulted in an ongoing global pandemic. It is unclear whether the relatively low number of reported cases of COVID-19 in people with CF (pwCF) is due to enhanced infection prevention practices or whether pwCF have protective genetic/immune factors. This study aims to prospectively assess the proportion of pwCF, including both adults and children with CF who have evidence of SARS-CoV-2 antibodies over a two-year period. This study will also examine whether pwCF who have antibodies for SARS-CoV-2 have a different clinical presentation and what impact this has on their CF disease. The proposed study will recruit pwCF from paediatric and adult CF centres in Europe. Serological testing to detect antibodies will be performed on blood samples taken at month 0, 6, 12, 18 and 24 with additional time-points if bloodwork is available via normal clinical care. Clinical data on, lung function, CF-related medical history, pulmonary exacerbations, antibiotic use, and microbiology and vaccination receipt, will be collected during routine clinical assessments. Associations will be examined between socio-demographic and clinical variables and serologic testing. The effects of SARS-CoV-2 infection on clinical outcomes and analyse end-points will be examined to explore any age-related or gender-based differences, as well as subgroup analysis of outcomes in lung-transplant recipients and pwCF receiving CFTR modulator therapies. As pwCF receive COVID-19 vaccination a comparison of the development and progression of anti-SARS-CoV-2 antibodies in pwCF following natural infection and vaccination SARS-CoV-2 over time will be performed
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Cystic Fibrosis patients | Other | Patients with cystic fibrosis, regardless of age, genetic profile, transplant status and disease severity will be eligible to participate in the study. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Blood sample | Biological | Blood serum samples will be collected for analysis of COVID-19 antibody levels. For participants who consent to the optional study, a second blood sample will also be drawn into EDTA tubes (plasma) |
| Measure | Description | Time Frame |
|---|---|---|
| SARS-COV-2 seroprevalence | Proportion of pwCF with at least 1 seropositive result over the study period and the difference in this proportion by age, geographical area and over time. | 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Association of SARS-CoV-2 seropositivity, clinical symptoms and clinical outcomes in pwCF | Incidence of symptomatic COVID-19 over the study period and severity; proportion of seropositive pwCF with subsequent CF exacerbation compared to pwCF who are seronegative; death rate in pwCF with at least one seropositive result compared to pwCF who are seronegative. | 2 years |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Refusal to give informed consent
Contraindication to venepuncture
For France
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| C.R.C.M. Pédiatrique (Centre de Ressources et de Compétences en Mucoviscidose) Hôpital des Enfants-Pellegrin - CHU de Bordeaux | Bordeaux | 33076 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| D003550 | Cystic Fibrosis |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
Not provided
Not provided
| ID | Term |
|---|---|
| D001800 | Blood Specimen Collection |
| ID | Term |
|---|---|
| D013048 | Specimen Handling |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Longitudinal comparison of the detection including level and duration of anti-SARS-CoV-2 antibodies in pwCF following natural infection and SARS-CoV-2 vaccination | Longitudinal comparison of the detection including level and duration of anti-SARS-CoV-2 antibodies in pwCF following natural infection and SARS-CoV-2 vaccination | 2 years |
| Serum proteomic and genomic responses of pwCF who are SARS-CoV-2 seropositive an seronegative | Serum proteomic and genomic responses of pwCF who are SARS-CoV-2 seropositive an seronegative | 10 years maximum |
| Pneumologie, allergologie et Mucoviscidose - CRCM Lyon pédiatrie Hôpital Femme Mère Enfant /Groupement Est | Bron | 69677 | France |
| Centre de Ressources et de Competences de la Mucoviscidose (Enfants) CHU Grenoble Alpes - Hôpital Couple Enfant | Grenoble | 38043 | France |
| Hôpital Albert Calmette - CHU de Lille | Lille | France |
| Hôpital Jeanne de Flandre | Lille | France |
| CHU Timone-Enfants - APHM | Marseille | France |
| Service des maladies respiratoires Hôpital Arnaud de Villeneuve - CHU de Montpellier | Montpellier | 34295 | France |
| CHU de Nice | Nice | 06002 | France |
| Hôpitaux Pédiatriques de Nice CHU Lenval | Nice | 06200 | France |
| Hôpital Cochin, AP-HP | Paris | France |
| Hôpital Necker Enfants Malades - APHP | Paris | France |
| Hôpital Robert Debré - APHP | Paris | France |
| Service de pédiatrie générale et spécialisée American Memorial Hospital - CHU de Reims | Reims | 51092 | France |
| Service de pneumologie - Centre cardio-pneumologie Hôpital Pontchaillou - CHU de Rennes | Rennes | 35033 | France |
| CRCM Pédiatrique Hôpital Sud - CHU de Rennes | Rennes | 35203 | France |
| Fondation Ildys | Roscoff | 29684 | France |
| Maladies respiratoires, allergologie - CRCM Mixte de Rouen Hôpital Charles Nicole - CHU de Rouen | Rouen | 76000 | France |
| Service de pneumo-allergologie pédiatrique CRCM pédiatrique CHU de Toulouse - Hôpital des Enfants | Toulouse | 31059 | France |
| Service Pneumologie-Allergologie CRCM adulte Hôpital Larrey - CHU de Toulouse | Toulouse | 31059 | France |
| D014777 |
| Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D010182 | Pancreatic Diseases |
| D004066 | Digestive System Diseases |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D007232 | Infant, Newborn, Diseases |
| D011677 | Punctures |
| D013514 | Surgical Procedures, Operative |
| D008919 | Investigative Techniques |